NanoCelle B12

NanoCelle B12
Product Description

B12 is a water-soluble compound, thus this foundation study was to determine NanoCelle® improvement in water-soluble compounds when compared to other more traditional forms, such as tablets, liquid emulsions, capsules, and liposomes.

Study outcomes, published, and allowed TGA to approve hieighten absorption claim in advertising.

See: https://www.medlab.group/nanocelle-b12

Medlab Group PTY LTD

  • AU
  • 2024
    On CPHI since
  • 1 - 24
    Employees
Company types
Biopharmaceutical company
Primary activities
Clinical Research
Marketing Services Provider
Out-licensing specialist
Specifications
  • Details
    Market ready, TGA approved for Australian partner.

    All the benefits of the delivery platform NanoCelle, inclusive of patent protection and the therapeutic values of B12. 


    Variants include both activated in non activated forms of B12.


    Product dosage at 1,000iu, but can scale up to 5,000IU.


    Studies show that NanoCelle B12 is 5x more bioavailable than a tablet, and up too 13x more than a liposome. Outcome of this published studied allowed TGA to approve claim in advertising.
  • Selling Points
    Product Features; Product Performance
  • Supplied from
    Australia

Medlab Group PTY LTD

  • AU
  • 2024
    On CPHI since
  • 1 - 24
    Employees
Company types
Biopharmaceutical company
Primary activities
Clinical Research
Marketing Services Provider
Out-licensing specialist

More Products from Medlab Group PTY LTD (1)

  • NanoCelle

    Product NanoCelle

     See https://www.medlab.group/what-is-nanocelle

    NanoCelle can be deployed in many molecules to enhance absorption, and increase patient compliance whilst reducing side effects.

Medlab Group PTY LTD resources (1)